Cutler Group LP Neogenomics Inc Call Options Transaction History

Cutler Group LP

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 04, 2022	BUY	$7.06 - $13.97 $14,826 - $29,337	2,100 Added 140.0%	3,600 $2,000
Q3 2021 Oct 26, 2021	SELL	$41.66 - $52.52 $4,166 - $5,252	-100 Reduced 6.25%	1,500 $2,000
Q2 2021 Jul 19, 2021	SELL	$36.62 - $51.69 $7,323 - $10,338	-200 Reduced 11.11%	1,600 $3,000
Q1 2021 Apr 26, 2021	SELL	$41.56 - $59.88 $37,404 - $53,892	-900 Reduced 33.33%	1,800 $10,000
Q4 2020 Jan 21, 2021	SELL	$36.08 - $56.47 $32,472 - $50,823	-900 Reduced 25.0%	2,700 $29,000
Q3 2020 Oct 27, 2020	BUY	$33.26 - $40.48 $86,476 - $105,247	2,600 Added 260.0%	3,600 $12,000
Q2 2020 Jul 22, 2020	BUY	$24.21 - $31.02 $16,947 - $21,714	700 Added 233.33%	1,000 $1,000
Q1 2020 May 07, 2020	SELL	$20.5 - $34.53 $563,750 - $949,575	-27,500 Reduced 98.92%	300 $0
Q3 2019 Oct 28, 2019	BUY	$19.12 - $26.24 $281,064 - $385,728	14,700 Added 112.21%	27,800 $2,000
Q2 2019 Aug 09, 2019	BUY	$19.57 - $24.1 $256,367 - $315,710	13,100 New	13,100 $19,000

296

125M

698K

116K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.7B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.